Immediate Impact

1 by Nobel laureates 3 from Science/Nature 54 standout
Sub-graph 1 of 24

Citing Papers

The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
1 intermediate paper

Works of Fei Kong being referenced

Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study
2020
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
2020

Author Peers

Author Last Decade Papers Cites
Fei Kong 361 100 70 184 179 77 1.0k
Koichi Fujisawa 494 99 117 97 128 66 1.1k
Lihua Yu 541 86 25 109 194 72 1.1k
Jean‐William Dupuy 724 45 64 127 310 75 1.4k
Ying Tong 413 55 58 104 107 67 966
Binghua Li 806 45 68 148 115 71 1.4k
Xinlei Li 486 210 29 79 126 62 1.0k
Lei Cui 533 144 86 100 246 56 1.2k
Xuan Wu 737 42 78 163 85 70 1.3k
Minghui He 839 58 47 148 118 35 1.2k
Qiang Ma 610 114 18 99 245 67 1.4k

All Works

Loading papers...

Rankless by CCL
2026